PL BioScience

🧪✨ 9th Bioproduction Congress in Tours, France

Our colleagues Cécilia Mesa and Anna Kolkmann are having an amazing time at the 9th Bioproduction Congress from 25-26 September.

You are as passionate about changing lives through science as we are?
🤝 Stop by📍Booth #30📍 to discuss the advancements happening in biopharmaceutical production and the role of Human Platelet Lysate.

Already at ISCT Europe 2024 in Gothenburg? We welcome you to stop by📍Booth .16📍
Connect with our team to discuss how our Human Platelet Lysates can support your cell therapy projects. We look forward to seeing you!

🚀 Celebrating a Major Milestone – Series A Funding Closed! 🚀

We are excited to share that PL BioScience has successfully closed our Series A financing round, securing an impressive €7.8 million! This significant milestone wouldn’t have been possible without the trust and support of our renowned investors.

A big thank you to the investors who believe in our vision:
- AVANT BIO
- LePure Biotech
- b.value AG
- better ventures
- Brightlands Venture Partners
- TechVision Fonds

Derived from upcycled donated blood, Human Platelet Lysate (HPL) offers a more ethical, sustainable and animal-free alternative to traditional cell culture media supplements. With this funding, we will be able to expand our production capabilities and solidify our position as a world-class provider of HPL, accelerating the innovations are developing within our product portfolio, and ensuring stable supply to researchers worldwide. 🧪🌎

Of course, none of this would be possible without the dedication of the PL BioScience team. Everyone’s passion and hard work continues to drive us forward. Together, we are helping to shape a xeno-free cell culture future!

Lastly, from all of us in Aachen to all our customers and partners around the world, thank you for your continued support and trust in us. As we enter this new chapter of our company journey, we are excited to reach new heights with everyone! 🌟

Read more in the press release: https://www.startbase.com/news/pl-bioscience-sichert-78-millionen-euro-in-series-a-finanzierung/?utm_source=hootsuite&utm_medium=Facebook&utm_term=&utm_content=&utm_campaign=SeriesAPressRelease

PL BioScience secures 7.8 million euros in Series A financing Aachen cell culture solution promotes global growth in the field of cell therapy.

🔜 One more week until ISSCR 2024 in Hamburg!

From 10-12 July, you will find us at the yearly gathering of stem cell scientists across geographies and disciplines. 🚀

📍Visit us at BOOTH 803 to discover our ELAREM Human Platelet Lysates.

Join us together with 4,000 scientists and let’s dive into the advances in stem cell research and regenerative medicine.